NANOVIRICIDES, INC. Prepaid Expense, Current
NANOVIRICIDES, INC. (NNVC) had Prepaid Expense, Current of $164.66 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-05-15
- 2026-03-31: Prepaid Expense, Current $164.66K.
- 2025-12-31: Prepaid Expense, Current $145.99K.
- 2025-09-30: Prepaid Expense, Current $126.86K.
- 2025-06-30: Prepaid Expense, Current $112.15K.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2026-03-31 | $164.66K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $145.99K 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $126.86K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $112.15K 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $184.72K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $113.81K 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $175.13K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $172.74K 10-K · filed 2025-09-29 | |
| 2024-03-31 | $258.55K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $72.44K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $173.28K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $295.49K 10-K · filed 2024-09-27 | |
| 2023-03-31 | $280.12K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $104.55K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $231.56K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $350.02K 10-K · filed 2023-10-13 | |
| 2022-03-31 | $337.18K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $141.90K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $195.68K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $307.10K 10-K · filed 2022-10-13 | |
| 2021-03-31 | $331.55K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $94.30K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $232.81K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $277.06K 10-K · filed 2021-10-12 | |
| 2020-03-31 | $331.77K 10-Q · filed 2020-06-22 | |
| 2019-12-31 | $257.83K 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $220.79K 10-Q · filed 2019-11-15 | |
| 2019-06-30 | $270.21K 10-K · filed 2020-10-13 | |
| 2019-03-31 | $393.24K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $168.95K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $201.53K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $240.26K 10-K · filed 2019-08-23 | |
| 2018-03-31 | $332.91K 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $239.53K 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $192.42K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $190.17K 10-K · filed 2018-10-12 | |
| 2017-03-31 | $217.28K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $139.72K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $207.56K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $219.46K 10-K · filed 2017-09-28 | |
| 2016-03-31 | $314.49K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $106.00K 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $163.49K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $214.43K 10-K · filed 2016-09-16 | |
| 2015-03-31 | $308.60K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $235.11K 10-Q · filed 2015-02-25 | |
| 2014-09-30 | $59.10K 10-Q/A · filed 2015-02-23 | |
| 2014-06-30 | $108.09K 10-K · filed 2015-09-14 | |
| 2014-03-31 | $1.34M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $806.39K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $805.14K 10-Q/A · filed 2015-02-23 | |
| 2013-06-30 | $51.60K 10-K · filed 2015-02-23 | $598.38K 10-K/A · filed 2013-10-08 |
| 2013-03-31 | $541.63K 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $801.59K 10-Q/A · filed 2013-02-22 | |
| 2012-09-30 | $438.34K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $314.17K 10-K/A · filed 2013-10-08 | |
| 2012-03-31 | $295.75K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $322.88K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $321.89K 10-Q/A · filed 2011-12-12 | |
| 2011-06-30 | $332.29K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |